Brief: PharmaSGP 9-Month Adj. EBITDA At EUR 13.2 Mln

PharmaSGP Holding SE

16/11/2021 06:38

Nov 16 (Reuters) - PHARMASGP HOLDING SE  PSGG.DE :
    * 9M GROUP REVENUE (EUR 46.2 MILLION)
    * PHARMASGP REPORTING 34% REVENUE GROWTH AND INCREASED
PROFITABILITY IN Q3 2021
    * 9-MONTH ADJUSTED EBITDA AT EUR 13.2 MILLION
    * EXECUTIVE BOARD CONTINUES TO ASSUME THAT FORECAST FOR 2021
FINANCIAL YEAR WILL BE ACHIEVED
    * OUTLOOK 2021: MANAGEMENT BOARD NOW EXPECTS REVENUES OF
BETWEEN
EUR 60 MILLION AND EUR 65 MILLION

Further company coverage:  PSGG.DE 

 (Gdansk Newsroom)
 ((Gdansk.Newsroom@thomsonreuters.com;))